Susquehanna Fundamental Investments, LLC Horizon Therapeutics Public LTD CO Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $4.74 Million - $6.82 Million	-80,526 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $6.96 Million - $8.84 Million	80,526 New	80,526 $8.47 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $6.93 Million - $8.43 Million	-70,296 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $15,609 - $17,361	-181 Reduced 0.26%	70,296 $6.58 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $854,274 - $1.14 Million	-11,893 Reduced 14.44%	70,477 $6.49 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $5.52 Million - $6.95 Million	82,370 New	82,370 $6.03 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.